Consistency of c-Met protein overexpression over time in patients with non-squamous non-small cell lung cancer
{{output}}
Aims: The c-Met signalling pathway is dysregulated in non-small cell lung cancer (NSCLC), with c-Met protein overexpression emerging as a potentially actionable biomarker given the development of c-Met-targeted antibody-drug conj... ...
